Article
Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
The Journal of infectious diseases - 15 Feb 2004
Hastings Michele D, Porter Kathryn M, Maguire Jason D, Susanti Ika, Kania Winni, Bangs Michael J, Sibley Carol Hopkins, Baird J Kevin
Abstract excerpt
BACKGROUND: The target enzyme of pyrimethamine is dihydrofolate reductase (DHFR), but little is known about allelic variants of dhfr in Plasmodium vivax populations. Still less is known about associations between specific alleles and the failure of sulfadoxine/pyrimethamine (S/P) to clear the ery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
